Evonik Evonik

X

CAS 201856-53-3 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 201856-53-3
Also known as: 201856-53-3, (3r,4s)-1-benzoyl-3-(1-ethoxyethoxy)-4-phenyl-2-azetidinone, Schembl1134975, Amy16038, Akos016005641, Ac-23879
Molecular Formula
C20H21NO4
Molecular Weight
339.4  g/mol
InChI Key
XSYLUBKWRZCOQP-CXRLMVSZSA-N

1 2D Structure

CAS 201856-53-3

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R,4S)-1-benzoyl-3-(1-ethoxyethoxy)-4-phenylazetidin-2-one
2.1.2 InChI
InChI=1S/C20H21NO4/c1-3-24-14(2)25-18-17(15-10-6-4-7-11-15)21(20(18)23)19(22)16-12-8-5-9-13-16/h4-14,17-18H,3H2,1-2H3/t14?,17-,18+/m0/s1
2.1.3 InChI Key
XSYLUBKWRZCOQP-CXRLMVSZSA-N
2.1.4 Canonical SMILES
CCOC(C)OC1C(N(C1=O)C(=O)C2=CC=CC=C2)C3=CC=CC=C3
2.1.5 Isomeric SMILES
CCOC(C)O[C@@H]1[C@@H](N(C1=O)C(=O)C2=CC=CC=C2)C3=CC=CC=C3
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 201856-53-3

2. (3r,4s)-1-benzoyl-3-(1-ethoxyethoxy)-4-phenyl-2-azetidinone

3. Schembl1134975

4. Amy16038

5. Akos016005641

6. Ac-23879

7. 856b533

8. A814313

9. J-501259

10. (3r,4s)-1-benzoyl-3-(1-ethoxyethoxy)-4-phenyl-azetidin-2-one

2.3 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 339.4 g/mol
Molecular Formula C20H21NO4
XLogP33.1
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count6
Exact Mass339.14705815 g/mol
Monoisotopic Mass339.14705815 g/mol
Topological Polar Surface Area55.8 Ų
Heavy Atom Count25
Formal Charge0
Complexity468
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
201856-53-3
Fujian South Pharmaceutical Co., Ltd. (Southern Pharmaceutical) was established in September 2001 and is ...
Fujian South Pharmaceutical Co., Ltd. (Southern Pharmaceutical) was established in September 2001 and is located in Mingxi County, Fujian Province. After 16 years of development, Nanfang Pharmaceutical has grown into a major domestic manufacturer of anti-tumor raw materials and intermediates, and has expanded to non-anti-tumor drugs. Using the company's accumulated rich experience and first-class technology in plant extraction, the company's product line has been expanded to the field of plant-derived products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY